Try our beta test site
all 237743 studies found for:    ALL
Show Display Options
Rank Status Study
21 Recruiting Identification/Characterization of Changes in Microscopic Colitis
Condition: Colitis, Microscopic
Intervention:
22 Not yet recruiting STAT Inhibitor OPB-111077 and Decitabine in Treating Patients With Acute Myeloid Leukemia That Is Refractory or Newly Diagnosed and Ineligible for Intensive Chemotherapy
Conditions: Acute Myeloid Leukemia;   Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: STAT Inhibitor OPB-111077;   Drug: Decitabine
23 Not yet recruiting Pain and Magnesium
Condition: Neuropathic Pain Induced by Mastectomy
Interventions: Drug: Magnesium: Magnésium UPSA Action Continue®;   Drug: Placebo: Lactose
24 Recruiting Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors
Conditions: Cancer Survivor;   Stage I Rectosigmoid Cancer;   Stage II Rectosigmoid Cancer;   Stage III Rectosigmoid Cancer
Interventions: Other: Informational Intervention;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Other: Survey Administration;   Behavioral: Telephone-Based Intervention
25 Recruiting The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
Conditions: Buprenorphine;   Pain
Intervention: Drug: Buprenorphine
26 Not yet recruiting Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion
Condition: Hip Fractures
Interventions: Drug: Tranexamic Acid (TXA);   Drug: Saline solution
27 Not yet recruiting Treating HCV in CRF Using Sofosbuvir and Daclatasvir
Conditions: Hepatitis C, Chronic;   Chronic Renal Failure
Intervention: Drug: Sofosbuvir 400 mg and daclatasvir 60 mg
28 Recruiting Randomised Controlled Study of Popofol Versus Midazolam as Sedation in Endoscopy With Advanced Liver Disease.
Condition: Liver Diseases
Interventions: Drug: Propofol;   Drug: Midazolam;   Drug: Fentanyl
29 Recruiting Removal of Surgical Staples After Cesarean Delivery. POD4 or POD8. A Randomized Control Trial.
Condition: Cesarean Section; Wound, Infection (Following Delivery)
Interventions: Other: Removal of surgical clips at day 4 postop vs day 8;   Procedure: Elective cesarean delivery
30 Enrolling by invitation Microwave Ablation for the Treatment of Malignant Liver Tumors Closed to Intrahepatic Vessels
Condition: Liver Cancer
Intervention: Device: Microwave ablation
31 Completed Effect of Botulinum Toxin A on Neurogenic Detrusor Overactivity in Chronic Spinal Cord Injured Patients
Condition: Neurogenic Bladder
Interventions: Drug: OnabotulinumtoxinA 200 UNT;   Diagnostic Test: Urothelial sensory protein levels
32 Completed Effects of App-based Versus Personal On-site Instruction on Neuromuscular Activity in Injury Prevention Exercises
Conditions: Musculoskeletal Injury;   Injury, Knee
Interventions: Behavioral: APP;   Behavioral: PHY
33 Not yet recruiting Study on the Transfusional Management of the Patients With Congenital Heart Disease Carried Out in Adulthood.
Condition: Congenital Heart Defect
Intervention: Other: Data extraction in medical files
34 Not yet recruiting Imaging the HIV Reservoir
Condition: HIV
Intervention: Drug: 3BNC117-Copper-64
35 Recruiting Proof of Concept: Socket Seal
Condition: Tissue Preservation
Interventions: Device: BioOss® + Mucograft Seal®;   Other: FGG + Bio-Oss®;   Other: FGG + Gelatine sponge (Spongostan®);   Device: Spongostan®+ Mucograft® Seal
36 Recruiting Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)
Condition: Renal Cell Carcinoma
Interventions: Drug: Obinutuzumab;   Drug: Atezolizumab;   Drug: Bevacizumab;   Drug: RO6874281
37 Not yet recruiting RESOLUTE ONYX Post-Approval Study
Condition: Coronary Artery Disease
Intervention: Device: Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
38 Not yet recruiting Entolimod for Vaccine Augmentation (VA)
Condition: Substance Use Disorders
Interventions: Drug: Entolimod;   Drug: Td Vaccine
39 Completed Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs
Condition: Chronic Hepatitis C (Disorder)
Interventions: Drug: Ledipasvir-Sofosbuvir;   Drug: Daclatasvir-Sofosbuvir
40 Temporarily not available Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients
Condition: PSR Ovarian Cancer With a BRCA Mutation
Intervention: Drug: olaparib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.